Aprea Therapeutics
APRE
APRE
25 hedge funds and large institutions have $521K invested in Aprea Therapeutics in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 5 closing their positions.
Holders
25
Holders Change
-2
Holders Change %
-7.41%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
7
Reduced
7
Closed
5
Calls
$186K
Puts
$4K
Net Calls
+$182K
Net Calls Change
-$195K
Top Buyers
| 1 |
1
Jane Street
New York
|
$16.9K |
| 2 |
2
Millennium Management
New York
|
$53K |
| 3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$15K |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$8.49K |
| 5 |
5
Group One Trading
Chicago,
Illinois
|
$14.2K |
